ReproCELLorp (TSE:4978) Total Liabilities: 円741 Mil (As of Mar. 2026)


TSE:4978 ReproCELL Incorp TSE:4978
61 GF Score
Price 円129.00
GF Value 円154.51
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is ReproCELLorp Total Liabilities?

ReproCELLorp TSE:4978 +1.57% 61 Total Liabilities is 円741 Mil as of Mar. 2026. GuruFocus rates TSE:4978 with a GF Score™ of 61/100 and a GF Value™ of 円154.51 (Modestly Undervalued). The stock has 3 warning signs investors should review.

ReproCELLorp's Total Liabilities for the quarter that ended in Mar. 2026 was 円741 Mil.

ReproCELLorp's quarterly Total Liabilities increased from Sep. 2025 (円688.22 Mil) to Dec. 2025 (円1,621.31 Mil) but then declined from Dec. 2025 (円1,621.31 Mil) to Mar. 2026 (円741.03 Mil).

ReproCELLorp's annual Total Liabilities declined from Mar. 2024 (円741.03 Mil) to Mar. 2025 (円685.81 Mil) but then increased from Mar. 2025 (円685.81 Mil) to Mar. 2026 (円741.03 Mil).

ReproCELLorp Total Liabilities Historical Data

* Premium members only.

The historical data trend for ReproCELLorp's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ReproCELLorp Total Liabilities Chart

ReproCELLorp Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 844.53 780.63 741.03 685.81 741.03

ReproCELLorp Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 685.81 591.25 688.22 1,621.31 741.03
TSE:4978
61GF Score
ReproCELL Incorp TSE:4978
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ReproCELLorp Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

ReproCELLorp's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=678.403+(0+62.631
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=741

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=9052.627-8311.593
=741

ReproCELLorp's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=678.403+(0+62.631
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=741

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=9052.627-8311.593
=741

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of 円741 Mil mean?
ReproCELLorp (TSE:4978) has a Total Liabilities of 円741 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for ReproCELLorp and its competitors.
Is ReproCELLorp's Total Liabilities too high?
ReproCELLorp's current Total Liabilities is 円741 Mil. Overall, ReproCELLorp has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ReproCELLorp's Total Liabilities compare to VRTX and REGN?
ReproCELLorp's Total Liabilities of 円741 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for ReproCELLorp and its competitors. ReproCELLorp's current Total Liabilities is 円741 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ReproCELLorp stock overvalued right now?
Based on GuruFocus' analysis, ReproCELLorp (TSE:4978) is currently considered Modestly Undervalued. The stock's GF Value™ is 円154.51, compared to a current price of 円129.00 — trading 16.5% below its estimated fair value. The current Total Liabilities is 円741 Mil. ReproCELLorp's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For ReproCELLorp (TSE:4978), the current Total Liabilities is 円741 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ReproCELLorp (TSE:4978) Overvalued in 2026?

Based on GuruFocus' analysis, ReproCELLorp stock appears to be undervalued. The current stock price of 円129.00 is trading 16.5% below its estimated GF Value™ of 円154.51. GuruFocus considers ReproCELLorp to be Modestly Undervalued.

Key valuation signals for TSE:4978:

  • Total Liabilities: 円741 Mil
  • GF Value™: 円154.51 vs. price of 円129.00 (16.5% below fair value)
  • GF Score™: 61/100 with 3 warning signs

No single metric tells the full story. See the TSE:4978 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ReproCELLorp Business Description

Address KDX Shin-Yokohama 381 Bldg. 9F, 3-8-11, Shin-Yokohama, Kohoku-ku, Kanagawa, Yokohama, JPN, 222-0033
ReproCELL Incorp is one of the leading stem cell research company in Japan. The company provides stem cell services, predictive drug discovery services, tissue services, and molecular services.
61GF Score

Get the complete analysis for TSE:4978

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円129.00
Price
円154.51
GF Value